Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ZYME
Stock Latest News
Ratings
Zymeworks’ Promising Clinical Developments and Strategic Positioning Justify Buy Rating
12d ago
ZYME
Premium
Ratings
Zymeworks: Hold Rating Amidst Milestone Achievements and Future Uncertainties
13d ago
ZYME
Premium
Ratings
Zymeworks: Strategic Milestones and Promising Clinical Results Justify Buy Rating
16d ago
ZYME
Premium
Ratings
Zymeworks’ Zanidatamab: Promising Potential in HER2-Positive Cancer Treatment and Strategic Market Positioning Justify Buy Rating
16d ago
ZYME
Premium
Company Announcements
Zymeworks’ Zanidatamab Receives NMPA Approval in China for HER2+ Biliary Tract Cancer
16d ago
ZYME
Premium
The Fly
Zymeworks announces NMPA approval of zanidatamab in China
16d ago
ZYME
Premium
Company Announcements
Zymeworks Showcases Oncology Advances at Major Conferences
24d ago
ZYME
Premium
Company Announcements
Zymeworks to Engage Investors at Upcoming Conferences
25d ago
ZYME
Premium
The Fly
MongoDB and Asana downgraded: Wall Street’s top analyst calls
26d ago
AL
CB
Premium
Ratings
Zymeworks: Hold Rating Maintained Amid Financial Improvements and Early-Stage Growth Potential
26d ago
ZYME
Premium
Ratings
Zymeworks: Buy Rating Driven by Innovative Pipeline and Strategic Partnerships
26d ago
ZYME
Premium
The Fly
Zymeworks initiated with a Buy at TD Cowen
26d ago
ZYME
Premium
Company Announcements
Zymeworks Unveils Promising Preclinical Data for Novel Respiratory Treatment
27d ago
ZYME
Premium
The Fly
Zymeworks presents new ZW1528 data at ATS conference
27d ago
ZYME
Premium
Ratings
Zymeworks’s Promising Pipeline and Strategic Partnerships Drive Buy Rating
1M ago
ZYME
Premium
Company Announcements
Zymeworks Earnings Call Highlights Growth and Partnerships
1M ago
ZYME
Premium
Company Announcements
Zymeworks Reports Q1 2025 Financial Results and R&D Progress
1M ago
ZYME
Premium
Ratings
Zymeworks: Strategic Positioning and Financial Health Drive Buy Rating
1M ago
ZYME
Premium
The Fly
Zymeworks reports Q1 EPS (30c), consensus (73c)
1M ago
ZYME
Premium
Company Announcements
Zymeworks Updates Communication Channels for Stakeholders
1M ago
8K
ZYME
Premium
Company Announcements
Zymeworks Unveils Promising Data on Novel Cancer Therapies at AACR 2025
2M ago
ZYME
Premium
Company Announcements
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment
2M ago
ZYME
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
